Diagnostic Testing

White Coat Sciences has special interest in diagnosis and treatment of diseases, viruses, and other pathogens. With the COVID19 pandemic, there have been several different methods of testing. At White Coat Sciences, we offer PCR (polymerase chain reaction) testing for COVID19 which has the current highest specificity and sensitivity. Unlike other laboratories, the methods and reagents utilized by us are FDA approved and we use CDC protocols. We also currently test for COVID19 antibodies in blood using ELISA (Enzyme Linked Immunosorbent Assay) which has the highest specificity and sensitivity compared to other antibody tests. If you are a patient and want to be tested for COVID19, contact USMedClinic to find a location nearest you.

If you are a clinic or business that is interested in utilizing our laboratory services for testing, please contact the lab.

*If you are a clinic that wants to become a ‘participating clinic’ and submit your patients’ blood for Antibody testing, contact the laboratory at 404-436-0009.


White Coat Sciences was founded in 2020 by Drs. Brent & Anna Harris with the goal of responding to the Covid-19 pandemic. We are transitioning into investing in new medical therapeutics focused on bringing innovative pharmaceutical drugs and medical devices to market. During the recent COVID-19 pandemic, our diagnostic testing has focused on Antibody serology and PCR testing for COVID-19.

Dr. Brent Harris is Board Certified in Family Medicine with undergraduate focuses in biology, organic chemistry, and physics. He is founder of US MedClinic, a group of direct pay Urgent Care & Family Medicine clinics in the Southeast. Dr. Anna Harris is a Board Certified Radiation Oncologist with an undergraduate degree in biochemistry. She has published in both scientific and medical journals as well as authored several books.



With the constant threat of new viruses and resistant bacteria, humanity is in desperate need of new drugs and therapeutics to help combat illness. Little has helped humanity advance more than the advent of antibiotics. At WhiteCoat Sciences, our mission is to develop antimicrobial medical devices, diagnostic laboratory services, and cutting edge pharmaceutics to help humanity battle the diseases of the 21st Century.

On the diagnostic side, we have COVID-19 testing including PCR analysis, ELISA serology for antibody detection, and other diagnostic tools in order to develop convalescent therapy. Within the pharmaceutical division, we are developing treatment solutions to help with respiratory infections such as influenza and the newly discovered coronavirus Covid-19.

We are also currently developing surgical closure devices that help decrease post-operative infections and innovative new catheter devices to help prevent nosocomial urinary infections.

We happily partner with other developing Biotechnology and Medical related companies for new endeavors, products, and services.


[email protected]

Main: 404-436-0009 Digital Fax: 404-436-0009

Covid-19 Diagnostics: 315 Bankhead Highway. Suite A. Carrollton, GA 30117